Selected research
Industry Growth & Trends
Global Chronic Pain Treatment Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Chronic Pain Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Chronic Pain Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Chronic Pain Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Chronic Pain Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Chronic Pain Treatment market include Sanofi, Johnson & Johnson, Novartis AG, Medtronic, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Boston Scientific Corporation and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Chronic Pain Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Chronic Pain Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chronic Pain Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chronic Pain Treatment.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Chronic Pain Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Chronic Pain Treatment Market by Company
Sanofi
Johnson & Johnson
Novartis AG
Medtronic
Eli Lilly and Company
Pfizer
GlaxoSmithKline
Boston Scientific Corporation
Bristol-Myers Squibb
AstraZeneca PLC
Becton, Dickinson and Company
Abbott Laboratories
Chronic Pain Treatment Segment by Type
Drugs
Devices
Chronic Pain Treatment Segment by Application
Research Centers
Nursing Homes
Hospitals
Clinics
Chronic Pain Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Pain Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chronic Pain Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Pain Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Chronic Pain Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Drugs
- Devices
Applications
- Research Centers
- Nursing Homes
- Hospitals
- Clinics
Companies covered
- Sanofi
- Johnson & Johnson
- Novartis AG
- Medtronic
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Boston Scientific Corporation
- Bristol-Myers Squibb
- AstraZeneca PLC
- Becton, Dickinson and Company
- Abbott Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Chronic Pain Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Chronic Pain Treatment Market Size by Region (2021-2032)
- 1.4.1 Global Chronic Pain Treatment Market Size by Region (2021-2026)
- 1.4.2 Global Chronic Pain Treatment Market Size by Region (2027-2032)
- 1.5 Key Regions Chronic Pain Treatment Market Size (2021-2032)
- 1.5.1 North America Chronic Pain Treatment Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Chronic Pain Treatment Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Chronic Pain Treatment Market Size Growth Rate (2021-2032)
- 1.5.4 South America Chronic Pain Treatment Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Chronic Pain Treatment Market Size Growth Rate (2021-2032)
2 Chronic Pain Treatment Market by Type
- 2.1 Type Introduction
- 2.1.1 Drugs
- 2.1.2 Devices
- 2.2 Global Chronic Pain Treatment Market Size by Type
- 2.2.1 Global Chronic Pain Treatment Market Size Overview by Type (2021-2032)
- 2.2.2 Global Chronic Pain Treatment Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Chronic Pain Treatment Market Size Forecasted by Type (2027-2032)
- 2.3 Global Chronic Pain Treatment Market Size by Regions
- 2.3.1 North America Chronic Pain Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Chronic Pain Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Chronic Pain Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Chronic Pain Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Chronic Pain Treatment Market Size Breakdown by Type (2021-2026)
3 Chronic Pain Treatment Market by Application
- 3.1 Type Introduction
- 3.1.1 Research Centers
- 3.1.2 Nursing Homes
- 3.1.3 Hospitals
- 3.1.4 Clinics
- 3.2 Global Chronic Pain Treatment Market Size by Application
- 3.2.1 Global Chronic Pain Treatment Market Size Overview by Application (2021-2032)
- 3.2.2 Global Chronic Pain Treatment Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Chronic Pain Treatment Market Size Forecasted by Application (2027-2032)
- 3.3 Global Chronic Pain Treatment Market Size by Regions
- 3.3.1 North America Chronic Pain Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Chronic Pain Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Chronic Pain Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Chronic Pain Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Chronic Pain Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Chronic Pain Treatment Industry Trends
- 4.2 Chronic Pain Treatment Industry Drivers
- 4.3 Chronic Pain Treatment Industry Opportunities and Challenges
- 4.4 Chronic Pain Treatment Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Chronic Pain Treatment Revenue (2021-2026)
- 5.2 Global Chronic Pain Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Chronic Pain Treatment Key Company Headquarters & Area Served
- 5.4 Global Chronic Pain Treatment Company, Product Type & Application
- 5.5 Global Chronic Pain Treatment Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Chronic Pain Treatment Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Chronic Pain Treatment Players Market Share by Revenue in 2025
- 5.6.3 2025 Chronic Pain Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Sanofi
- 6.1.1 Sanofi Company Information
- 6.1.2 Sanofi Business Overview
- 6.1.3 Sanofi Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Sanofi Chronic Pain Treatment Product Portfolio
- 6.1.5 Sanofi Recent Developments
- 6.2 Johnson & Johnson
- 6.2.1 Johnson & Johnson Company Information
- 6.2.2 Johnson & Johnson Business Overview
- 6.2.3 Johnson & Johnson Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Johnson & Johnson Chronic Pain Treatment Product Portfolio
- 6.2.5 Johnson & Johnson Recent Developments
- 6.3 Novartis AG
- 6.3.1 Novartis AG Company Information
- 6.3.2 Novartis AG Business Overview
- 6.3.3 Novartis AG Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Novartis AG Chronic Pain Treatment Product Portfolio
- 6.3.5 Novartis AG Recent Developments
- 6.4 Medtronic
- 6.4.1 Medtronic Company Information
- 6.4.2 Medtronic Business Overview
- 6.4.3 Medtronic Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Medtronic Chronic Pain Treatment Product Portfolio
- 6.4.5 Medtronic Recent Developments
- 6.5 Eli Lilly and Company
- 6.5.1 Eli Lilly and Company Company Information
- 6.5.2 Eli Lilly and Company Business Overview
- 6.5.3 Eli Lilly and Company Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Eli Lilly and Company Chronic Pain Treatment Product Portfolio
- 6.5.5 Eli Lilly and Company Recent Developments
- 6.6 Pfizer
- 6.6.1 Pfizer Company Information
- 6.6.2 Pfizer Business Overview
- 6.6.3 Pfizer Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Pfizer Chronic Pain Treatment Product Portfolio
- 6.6.5 Pfizer Recent Developments
- 6.7 GlaxoSmithKline
- 6.7.1 GlaxoSmithKline Company Information
- 6.7.2 GlaxoSmithKline Business Overview
- 6.7.3 GlaxoSmithKline Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 GlaxoSmithKline Chronic Pain Treatment Product Portfolio
- 6.7.5 GlaxoSmithKline Recent Developments
- 6.8 Boston Scientific Corporation
- 6.8.1 Boston Scientific Corporation Company Information
- 6.8.2 Boston Scientific Corporation Business Overview
- 6.8.3 Boston Scientific Corporation Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Boston Scientific Corporation Chronic Pain Treatment Product Portfolio
- 6.8.5 Boston Scientific Corporation Recent Developments
- 6.9 Bristol-Myers Squibb
- 6.9.1 Bristol-Myers Squibb Company Information
- 6.9.2 Bristol-Myers Squibb Business Overview
- 6.9.3 Bristol-Myers Squibb Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Bristol-Myers Squibb Chronic Pain Treatment Product Portfolio
- 6.9.5 Bristol-Myers Squibb Recent Developments
- 6.10 AstraZeneca PLC
- 6.10.1 AstraZeneca PLC Company Information
- 6.10.2 AstraZeneca PLC Business Overview
- 6.10.3 AstraZeneca PLC Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 AstraZeneca PLC Chronic Pain Treatment Product Portfolio
- 6.10.5 AstraZeneca PLC Recent Developments
- 6.11 Becton, Dickinson and Company
- 6.11.1 Becton, Dickinson and Company Company Information
- 6.11.2 Becton, Dickinson and Company Business Overview
- 6.11.3 Becton, Dickinson and Company Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Becton, Dickinson and Company Chronic Pain Treatment Product Portfolio
- 6.11.5 Becton, Dickinson and Company Recent Developments
- 6.12 Abbott Laboratories
- 6.12.1 Abbott Laboratories Company Information
- 6.12.2 Abbott Laboratories Business Overview
- 6.12.3 Abbott Laboratories Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Abbott Laboratories Chronic Pain Treatment Product Portfolio
- 6.12.5 Abbott Laboratories Recent Developments
7 North America
- 7.1 North America Chronic Pain Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Chronic Pain Treatment Market Size by Country (2021-2026)
- 7.3 North America Chronic Pain Treatment Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Chronic Pain Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Chronic Pain Treatment Market Size by Country (2021-2026)
- 8.3 Europe Chronic Pain Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Chronic Pain Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Chronic Pain Treatment Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Chronic Pain Treatment Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Chronic Pain Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Chronic Pain Treatment Market Size by Country (2021-2026)
- 10.3 South America Chronic Pain Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Chronic Pain Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Chronic Pain Treatment Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Chronic Pain Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst